AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
46 hedge funds and large institutions have $68.1M invested in Agile Therapeutics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
39% more funds holding
Funds holding: 33 → 46 (+13)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
46
Holding in Top 10
1
Calls
$758K
Puts
$389K
Top Buyers
| 1 | +$2.98M | |
| 2 | +$2.22M | |
| 3 | +$2.09M | |
| 4 |
BlackRock
New York
|
+$1.97M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$819K |
Top Sellers
| 1 | -$1.89M | |
| 2 | -$747K | |
| 3 | -$511K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$195K |
| 5 |
Millennium Management
New York
|
-$105K |